Medtronic, Inc. (NYSE: MDT) today announced that the FDA has cleared the OneTouch UltraLink Meter as the new wireless meter exclusively certified by Medtronic to wirelessly communicate with Medtronic diabetes management products in the United States. This new meter uses Medtronic-certified wireless technology to transmit glucose readings directly to MiniMed Paradigm insulin pumps and the Guardian REAL-Time Continuous Glucose Monitoring System. This makes bolus dosing more accurate and easier for patients compared to the manual entry of blood glucose readings.

The OneTouch UltraLink Meter is the newest addition to the long-trusted OneTouch Meter Family - the number one prescribed meter brand - and uses OneTouch Ultra Test Strips, the number-one selling test strip in the United States. Data transmitted from the OneTouch UltraLink Meter can be viewed via Medtronic’s proprietary CareLink Therapy Management Software, the only software that integrates meter, logbook, insulin pump and real-time continuous glucose monitoring information to help patients and physicians more easily assess and manage diabetes.

“At Medtronic, we are committed to leading the technology revolution in diabetes management and delivering best-in-class solutions to patients,” said Chris O’Connell, president of the Diabetes business at Medtronic. “Together with LifeScan, we will continue to advance the opportunities for people with diabetes to proactively and conveniently manage their diabetes while maximizing their quality of life.”

Medtronic is actively working to provide the OneTouch UltraLink Meter to all of its customers as soon as possible, and is taking a staged product launch approach. All new U.S. customers who order a MiniMed Paradigm REAL-Time System or Guardian REAL-Time System will receive the OneTouch UltraLink Meter at no charge. The company will immediately start shipping the new meters at no charge to eligible U.S. customers, and plans to complete this process later this year.

Medtronic currently markets the MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System – the world’s only insulin pump with REAL-Time continuous glucose monitoring (CGM). The MiniMed Paradigm REAL-Time System has all of the benefits of CGM plus the added value of precise insulin delivery through the use of insulin pump therapy.

Related posts

• Advantage Medical Devices Receives FDA Clearance for VantageCath (0)
• FATAL CARE: Survive In The U.S. Health System (0)
• FDA Clears First Medical Product Made From Yulex Natural Rubber (0)
• Novel Antipsychotic Drug for Patients with Schizophrenia (0)
• Alcon’s PATANASE Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms (0)